Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 2 | 2024 | 16 | 1.680 |
Why?
|
| Memory | 7 | 2020 | 55 | 1.410 |
Why?
|
| Hippocampus | 7 | 2014 | 73 | 1.280 |
Why?
|
| Pattern Recognition, Visual | 6 | 2014 | 34 | 1.160 |
Why?
|
| Anesthetics, Inhalation | 3 | 2017 | 6 | 1.150 |
Why?
|
| Cell Wall | 3 | 2024 | 13 | 1.110 |
Why?
|
| Candida | 3 | 2024 | 13 | 1.110 |
Why?
|
| Female | 37 | 2024 | 2811 | 1.080 |
Why?
|
| Candidiasis | 3 | 2021 | 8 | 1.070 |
Why?
|
| Male | 31 | 2024 | 2765 | 1.020 |
Why?
|
| Animals | 24 | 2024 | 1817 | 0.930 |
Why?
|
| Glycosylphosphatidylinositols | 2 | 2024 | 2 | 0.920 |
Why?
|
| Blood Glucose | 2 | 2024 | 31 | 0.880 |
Why?
|
| Triglycerides | 1 | 2024 | 7 | 0.870 |
Why?
|
| Discrimination Learning | 2 | 2016 | 6 | 0.870 |
Why?
|
| Zika Virus Infection | 3 | 2020 | 3 | 0.840 |
Why?
|
| Military Personnel | 5 | 2021 | 23 | 0.830 |
Why?
|
| Humans | 35 | 2024 | 5476 | 0.820 |
Why?
|
| Proteome | 1 | 2023 | 9 | 0.820 |
Why?
|
| Fungal Proteins | 5 | 2024 | 8 | 0.820 |
Why?
|
| Macaca mulatta | 13 | 2020 | 126 | 0.760 |
Why?
|
| Mycological Typing Techniques | 1 | 2020 | 1 | 0.700 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1 | 0.700 |
Why?
|
| Temporal Lobe | 2 | 2014 | 19 | 0.670 |
Why?
|
| Photic Stimulation | 3 | 2016 | 148 | 0.650 |
Why?
|
| Methyl Ethers | 2 | 2016 | 2 | 0.630 |
Why?
|
| Underage Drinking | 1 | 2018 | 5 | 0.600 |
Why?
|
| Impulsive Behavior | 1 | 2018 | 11 | 0.590 |
Why?
|
| Bass | 2 | 2015 | 3 | 0.590 |
Why?
|
| Marijuana Use | 1 | 2018 | 11 | 0.590 |
Why?
|
| Candida glabrata | 3 | 2022 | 6 | 0.570 |
Why?
|
| Zika Virus | 2 | 2020 | 2 | 0.570 |
Why?
|
| Haplorhini | 2 | 2017 | 6 | 0.560 |
Why?
|
| Genomics | 3 | 2024 | 44 | 0.560 |
Why?
|
| Memory Disorders | 3 | 2010 | 40 | 0.530 |
Why?
|
| Behavior, Animal | 3 | 2016 | 23 | 0.530 |
Why?
|
| Fetal Diseases | 1 | 2016 | 1 | 0.520 |
Why?
|
| Microcephaly | 1 | 2016 | 1 | 0.520 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2016 | 2 | 0.520 |
Why?
|
| Child Development | 1 | 2016 | 35 | 0.500 |
Why?
|
| Visual Perception | 1 | 2016 | 61 | 0.490 |
Why?
|
| Object Attachment | 1 | 2016 | 25 | 0.490 |
Why?
|
| Brain | 5 | 2020 | 286 | 0.470 |
Why?
|
| Pituitary Gland | 1 | 2015 | 1 | 0.470 |
Why?
|
| Kisspeptins | 1 | 2015 | 1 | 0.470 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2015 | 2 | 0.470 |
Why?
|
| Fish Proteins | 1 | 2015 | 2 | 0.470 |
Why?
|
| Candida albicans | 3 | 2024 | 4 | 0.470 |
Why?
|
| Spermatogenesis | 1 | 2015 | 2 | 0.470 |
Why?
|
| Melatonin | 1 | 2015 | 13 | 0.470 |
Why?
|
| Space Perception | 3 | 2013 | 21 | 0.440 |
Why?
|
| Chile | 7 | 2018 | 7 | 0.400 |
Why?
|
| Alcohol-Related Disorders | 2 | 2010 | 17 | 0.400 |
Why?
|
| Biomarkers | 2 | 2024 | 87 | 0.350 |
Why?
|
| Chagas Disease | 2 | 2021 | 2 | 0.350 |
Why?
|
| Adult | 10 | 2024 | 1683 | 0.350 |
Why?
|
| Ibotenic Acid | 6 | 2014 | 6 | 0.350 |
Why?
|
| Myocardial Ischemia | 1 | 2010 | 4 | 0.350 |
Why?
|
| Decision Making | 1 | 2010 | 12 | 0.340 |
Why?
|
| Leishmaniasis, Cutaneous | 2 | 2020 | 2 | 0.320 |
Why?
|
| Aged | 6 | 2024 | 859 | 0.310 |
Why?
|
| Surveys and Questionnaires | 2 | 2010 | 277 | 0.300 |
Why?
|
| Biofilms | 3 | 2023 | 27 | 0.300 |
Why?
|
| Food Hypersensitivity | 2 | 2018 | 3 | 0.300 |
Why?
|
| Middle Aged | 7 | 2024 | 1098 | 0.290 |
Why?
|
| Parahippocampal Gyrus | 2 | 2005 | 2 | 0.290 |
Why?
|
| Insulin Resistance | 2 | 2024 | 9 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 250 | 0.280 |
Why?
|
| Parkinson Disease | 2 | 2023 | 89 | 0.280 |
Why?
|
| Risk Factors | 3 | 2024 | 184 | 0.270 |
Why?
|
| Genome, Fungal | 2 | 2024 | 3 | 0.270 |
Why?
|
| Animals, Newborn | 5 | 2018 | 37 | 0.270 |
Why?
|
| Prospective Studies | 4 | 2024 | 132 | 0.260 |
Why?
|
| Case-Control Studies | 3 | 2024 | 96 | 0.250 |
Why?
|
| Computational Biology | 2 | 2024 | 42 | 0.250 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 350 | 0.250 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 71 | 0.250 |
Why?
|
| Child | 3 | 2018 | 657 | 0.240 |
Why?
|
| Spatial Behavior | 1 | 2005 | 4 | 0.230 |
Why?
|
| Trypanosoma cruzi | 2 | 2021 | 3 | 0.230 |
Why?
|
| Allergens | 2 | 2021 | 2 | 0.230 |
Why?
|
| Immunoglobulin E | 2 | 2021 | 9 | 0.220 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 5 | 0.220 |
Why?
|
| Dog Diseases | 1 | 2024 | 3 | 0.220 |
Why?
|
| beta-Glucans | 1 | 2024 | 2 | 0.220 |
Why?
|
| Colombia | 5 | 2021 | 9 | 0.210 |
Why?
|
| Pichia | 1 | 2023 | 1 | 0.210 |
Why?
|
| Obesity | 2 | 2018 | 118 | 0.210 |
Why?
|
| Proteomics | 1 | 2023 | 23 | 0.210 |
Why?
|
| Pessimism | 1 | 2022 | 1 | 0.200 |
Why?
|
| Zebrafish | 1 | 2022 | 21 | 0.200 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 107 | 0.190 |
Why?
|
| Ape Diseases | 1 | 2022 | 1 | 0.190 |
Why?
|
| Echocardiography, Stress | 1 | 2022 | 1 | 0.190 |
Why?
|
| Brain Diseases | 1 | 2002 | 4 | 0.190 |
Why?
|
| Amygdala | 1 | 2002 | 8 | 0.190 |
Why?
|
| Triatominae | 1 | 2021 | 1 | 0.190 |
Why?
|
| Zoonoses | 1 | 2021 | 1 | 0.190 |
Why?
|
| Insect Vectors | 1 | 2021 | 4 | 0.190 |
Why?
|
| Adolescent | 4 | 2024 | 806 | 0.180 |
Why?
|
| Teaching | 1 | 2021 | 13 | 0.180 |
Why?
|
| Housing | 1 | 2021 | 11 | 0.180 |
Why?
|
| HIV Infections | 1 | 2024 | 115 | 0.180 |
Why?
|
| Age Factors | 3 | 2016 | 75 | 0.180 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 44 | 0.180 |
Why?
|
| Organ Specificity | 2 | 2015 | 11 | 0.180 |
Why?
|
| Leishmania braziliensis | 1 | 2020 | 1 | 0.180 |
Why?
|
| Pentamidine | 1 | 2020 | 1 | 0.180 |
Why?
|
| Antiprotozoal Agents | 1 | 2020 | 3 | 0.180 |
Why?
|
| Genes, Fungal | 1 | 2020 | 1 | 0.180 |
Why?
|
| Indans | 1 | 2020 | 9 | 0.170 |
Why?
|
| Species Specificity | 1 | 2020 | 15 | 0.170 |
Why?
|
| DNA Primers | 1 | 2020 | 17 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 20 | 0.170 |
Why?
|
| Antifungal Agents | 1 | 2020 | 18 | 0.170 |
Why?
|
| Genetic Variation | 1 | 2020 | 36 | 0.170 |
Why?
|
| Pregnancy | 2 | 2018 | 103 | 0.160 |
Why?
|
| Analysis of Variance | 2 | 2016 | 81 | 0.150 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2018 | 1 | 0.150 |
Why?
|
| Food | 1 | 2018 | 2 | 0.150 |
Why?
|
| Menopause | 2 | 2009 | 6 | 0.150 |
Why?
|
| Metabolomics | 1 | 2018 | 6 | 0.150 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 19 | 0.150 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 2 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 4 | 0.150 |
Why?
|
| Dietary Supplements | 1 | 2018 | 8 | 0.150 |
Why?
|
| Basophils | 1 | 2018 | 1 | 0.150 |
Why?
|
| Mouth Mucosa | 1 | 2018 | 1 | 0.150 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2018 | 1 | 0.150 |
Why?
|
| Models, Psychological | 1 | 2018 | 32 | 0.150 |
Why?
|
| Fatty Acids | 1 | 2018 | 11 | 0.150 |
Why?
|
| Tight Junctions | 1 | 2018 | 10 | 0.150 |
Why?
|
| Overweight | 1 | 2018 | 41 | 0.140 |
Why?
|
| Neural Pathways | 2 | 2010 | 41 | 0.140 |
Why?
|
| Topography, Medical | 1 | 2017 | 1 | 0.140 |
Why?
|
| Phylogeography | 1 | 2017 | 2 | 0.140 |
Why?
|
| Leishmania | 1 | 2017 | 4 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2016 | 131 | 0.140 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2016 | 1 | 0.130 |
Why?
|
| Maternal Deprivation | 1 | 2016 | 1 | 0.130 |
Why?
|
| Infant | 1 | 2016 | 87 | 0.130 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 176 | 0.120 |
Why?
|
| Sexual Maturation | 1 | 2015 | 4 | 0.120 |
Why?
|
| Breeding | 1 | 2015 | 1 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 242 | 0.120 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 58 | 0.120 |
Why?
|
| Seasons | 1 | 2015 | 11 | 0.120 |
Why?
|
| Association | 1 | 2014 | 2 | 0.110 |
Why?
|
| Thalamus | 1 | 2014 | 7 | 0.110 |
Why?
|
| Gene Expression | 1 | 2015 | 52 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 77 | 0.110 |
Why?
|
| Emotions | 1 | 2015 | 83 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 13 | 0.110 |
Why?
|
| Health Behavior | 2 | 2012 | 38 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2015 | 88 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2014 | 31 | 0.110 |
Why?
|
| Neurotoxins | 2 | 2005 | 2 | 0.110 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 39 | 0.110 |
Why?
|
| Food Preferences | 1 | 2013 | 4 | 0.100 |
Why?
|
| Association Learning | 1 | 2013 | 5 | 0.100 |
Why?
|
| Dogs | 2 | 2024 | 17 | 0.100 |
Why?
|
| Young Adult | 4 | 2020 | 850 | 0.100 |
Why?
|
| Cognition | 3 | 2022 | 174 | 0.100 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 49 | 0.100 |
Why?
|
| Community-Institutional Relations | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 284 | 0.100 |
Why?
|
| Self Concept | 1 | 2012 | 20 | 0.090 |
Why?
|
| Enteropathy-Associated T-Cell Lymphoma | 1 | 2011 | 1 | 0.090 |
Why?
|
| Health Promotion | 1 | 2012 | 39 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 320 | 0.090 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2010 | 2 | 0.090 |
Why?
|
| Signal Detection, Psychological | 1 | 2010 | 4 | 0.090 |
Why?
|
| Hypertension | 1 | 2012 | 61 | 0.090 |
Why?
|
| Birth Weight | 1 | 2010 | 4 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2010 | 4 | 0.080 |
Why?
|
| Pollen | 2 | 2021 | 4 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 2 | 0.080 |
Why?
|
| Translating | 1 | 2010 | 5 | 0.080 |
Why?
|
| Reference Values | 1 | 2010 | 28 | 0.080 |
Why?
|
| Sexuality | 1 | 2009 | 2 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2010 | 100 | 0.080 |
Why?
|
| Genotype | 2 | 2021 | 58 | 0.080 |
Why?
|
| DNA, Protozoan | 2 | 2020 | 3 | 0.080 |
Why?
|
| Substance Abuse Detection | 1 | 2009 | 1 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2020 | 38 | 0.080 |
Why?
|
| Psychomotor Performance | 2 | 2014 | 107 | 0.080 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 22 | 0.080 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2008 | 1 | 0.070 |
Why?
|
| Psychometrics | 1 | 2009 | 101 | 0.070 |
Why?
|
| Social Support | 1 | 2008 | 31 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 52 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2022 | 119 | 0.070 |
Why?
|
| Motor Activity | 1 | 2007 | 66 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 72 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 4 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 19 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2005 | 12 | 0.060 |
Why?
|
| Denervation | 1 | 2005 | 1 | 0.060 |
Why?
|
| Learning | 1 | 2005 | 50 | 0.060 |
Why?
|
| Heart Atria | 1 | 2024 | 4 | 0.060 |
Why?
|
| Dilatation | 1 | 2024 | 2 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2005 | 78 | 0.060 |
Why?
|
| Mitral Valve | 1 | 2024 | 7 | 0.060 |
Why?
|
| Echocardiography | 1 | 2024 | 10 | 0.060 |
Why?
|
| Aorta | 1 | 2024 | 9 | 0.050 |
Why?
|
| Venezuela | 1 | 2024 | 1 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 4 | 0.050 |
Why?
|
| Pandemics | 1 | 2024 | 82 | 0.050 |
Why?
|
| Bias | 1 | 2022 | 9 | 0.050 |
Why?
|
| Judgment | 1 | 2022 | 12 | 0.050 |
Why?
|
| Caregivers | 1 | 2023 | 42 | 0.050 |
Why?
|
| Plastics | 1 | 2022 | 4 | 0.050 |
Why?
|
| Chromosomes | 1 | 2022 | 4 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 117 | 0.050 |
Why?
|
| Pongo pygmaeus | 1 | 2022 | 1 | 0.050 |
Why?
|
| Virulence Factors | 1 | 2021 | 4 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 6 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2021 | 10 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2022 | 7 | 0.050 |
Why?
|
| Pyroglyphidae | 1 | 2021 | 2 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2022 | 32 | 0.050 |
Why?
|
| Egypt | 1 | 2021 | 1 | 0.050 |
Why?
|
| Antigens, Protozoan | 1 | 2021 | 1 | 0.050 |
Why?
|
| Linear Models | 1 | 2022 | 60 | 0.050 |
Why?
|
| Mammals | 1 | 2021 | 19 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2021 | 87 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2020 | 1 | 0.040 |
Why?
|
| Haplotypes | 1 | 2020 | 12 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 66 | 0.040 |
Why?
|
| Aging | 1 | 2002 | 127 | 0.040 |
Why?
|
| Social Behavior | 1 | 2020 | 26 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2020 | 25 | 0.040 |
Why?
|
| Nerve Net | 1 | 2020 | 46 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2020 | 212 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2018 | 2 | 0.040 |
Why?
|
| Metabolome | 1 | 2018 | 6 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2018 | 8 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2018 | 2 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 23 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 13 | 0.040 |
Why?
|
| Profilins | 1 | 2018 | 1 | 0.040 |
Why?
|
| Claudin-1 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2018 | 3 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2018 | 5 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 38 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 55 | 0.040 |
Why?
|
| Phenotype | 1 | 2018 | 73 | 0.040 |
Why?
|
| Poaceae | 1 | 2018 | 21 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 27 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 6 | 0.030 |
Why?
|
| Photoperiod | 1 | 2015 | 1 | 0.030 |
Why?
|
| Endocrine System | 1 | 2015 | 2 | 0.030 |
Why?
|
| Sex Differentiation | 1 | 2015 | 2 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2015 | 36 | 0.030 |
Why?
|
| Craniotomy | 1 | 2013 | 2 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2013 | 11 | 0.030 |
Why?
|
| Reward | 1 | 2013 | 10 | 0.030 |
Why?
|
| Cues | 1 | 2013 | 39 | 0.020 |
Why?
|
| Celiac Disease | 1 | 2011 | 2 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 59 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 53 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2012 | 46 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 251 | 0.020 |
Why?
|
| Brazil | 1 | 2010 | 1 | 0.020 |
Why?
|
| Gestational Age | 1 | 2010 | 6 | 0.020 |
Why?
|
| Cities | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cholesterol | 1 | 2010 | 18 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2012 | 382 | 0.020 |
Why?
|
| Contraception | 1 | 2009 | 4 | 0.020 |
Why?
|
| Translations | 1 | 2009 | 5 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 31 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 136 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 26 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 97 | 0.020 |
Why?
|
| Reproductive History | 1 | 2007 | 1 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2007 | 4 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 43 | 0.020 |
Why?
|
| Insulin | 1 | 2007 | 31 | 0.020 |
Why?
|
| Benzo(a)pyrene | 1 | 2005 | 2 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 10 | 0.010 |
Why?
|
| Genes, ras | 1 | 2005 | 2 | 0.010 |
Why?
|
| beta Catenin | 1 | 2005 | 8 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 14 | 0.010 |
Why?
|
| Disease Progression | 1 | 2005 | 74 | 0.010 |
Why?
|
| Cerebral Decortication | 1 | 2004 | 1 | 0.010 |
Why?
|
| Reaction Time | 1 | 2004 | 60 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 176 | 0.010 |
Why?
|
| Silver Staining | 1 | 2002 | 1 | 0.010 |
Why?
|
| Cell Death | 1 | 2002 | 21 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 2002 | 56 | 0.010 |
Why?
|